EVP and CFO
EVP and CFO at MADRIGAL PHARMACEUTICALS, INC., filing insider transactions between 2026-03-02 and 2026-03-06.
| SEC ↗ |
| 2026-03-06 | MDGL | Sale | 160 | $429.00 | $69K | SEC ↗ |
| 2026-03-06 | MDGL | Sale | 160 | $434.20 | $69K | SEC ↗ |
| 2026-03-06 | MDGL | Sale | 40 | $425.08 | $17K | SEC ↗ |
| 2026-03-06 | MDGL | Sale | 40 | $429.58 | $17K | SEC ↗ |
| 2026-03-06 | MDGL | Sale | 40 | $437.65 | $18K | SEC ↗ |
| 2026-03-06 | MDGL | Sale | 420 | $426.86 | $179K | SEC ↗ |
| 2026-03-06 | MDGL | Sale | 646 | $431.94 | $279K | SEC ↗ |
| 2026-03-06 | MDGL | Sale | 80 | $427.85 | $34K | SEC ↗ |
| 2026-03-06 | MDGL | Sale | 80 | $435.31 | $35K | SEC ↗ |
| 2026-03-02 | MDGL | Sale | 1,183 | $427.21 | $505K | SEC ↗ |